HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Plasma lipoprotein levels and functional status of thrombocytes in patients with ischemic heart disease during treatment with essential phospholipids].

Abstract
Variations in platelet aggregation activity before and after the control of lipid metabolism with lecithin linoleate (essential preparation, 1800 mg EPL daily) were examined in coronary patients with pronounced hyperlipidemia. A considerable change was noted in the ratios of LP fractions, that is, rising HDLP in the presence of decreasing total plasma lipids, Changes in plasma lipid composition were accompanied with a reduction of platelet aggregation activity that persisted for 3 months following the discontinuation of the drug. Correlation and regression analyses of relationships between platelet aggregation and HDLP levels were carried out.
AuthorsS S Belousova, S I Bogoslovskaia, L M Silagina
JournalKardiologiia (Kardiologiia) Vol. 25 Issue 9 Pg. 112-5 (Sep 1985) ISSN: 0022-9040 [Print] Russia (Federation)
Vernacular TitleUroven' lipoproteidov v plazme krovi i funktsional'noe sostoianie trombotsitov u bol'nykh ishemicheskoĭ bolezn'iu serdtsa pri terapii éssentsial'nymi fosfolipidami.
PMID4079219 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Lipids
  • Lipoproteins
  • Lipoproteins, HDL
  • Phosphatidylcholines
  • essential 303 forte
Topics
  • Adult
  • Coronary Disease (blood, complications, drug therapy)
  • Humans
  • Hyperlipoproteinemias (complications, drug therapy)
  • Lipids (blood)
  • Lipoproteins (blood)
  • Lipoproteins, HDL (blood)
  • Middle Aged
  • Phosphatidylcholines (therapeutic use)
  • Platelet Aggregation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: